Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Older adults use lifestyle drugs to improve life quality and appearance, but caution is needed due to side effects and potential abuse.

Ancient hair can preserve hormones, revealing health and fertility insights.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Women with PCOS have more severe liver disease.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Acupuncture may be a safe and cost-effective treatment for Seborrheic alopecia.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Thyroid problems can cause hair loss and change hair texture.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.